Curious if this old blog is why the FDA requested a preliminary meeting. Probably because the initial 2 patients not enough? Kinda ok with it though because I think a face to face with Dr. Patterson and data will increase our chances.

http://www.fdalawblog.net/2016/03/fda-updates...ion-reque/